Bleichroeder’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.84M Hold
250,000
– – 0.38% 49
2026
Q2
$4.55M Buy
250,000
+150,000
+150% +$2.23M 0.81% 17
2026
Q1
$1.42M Buy
+100,000
New +$1.29M 0.25% 35

Other funds holding CGEM

Bleichroeder's CGEM Position: Q3 2026 in Review

Bleichroeder held its Cullinan Oncology (CGEM) position steady in Q3 2026 at 250,000 shares worth $3.84M. The position accounts for 0.38% of the portfolio, ranked #49.

Bleichroeder first reported a position in CGEM in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.55M in Q2 2026. 125 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

  • Bleichroeder held 250,000 shares of Cullinan Oncology worth $3.84M as of Q3 2026.
  • Bleichroeder left its Cullinan Oncology share count unchanged in Q3 2026.
  • Cullinan Oncology made up 0.38% of Bleichroeder's portfolio in Q3 2026, its #49 holding.
  • Bleichroeder first reported a position in Cullinan Oncology in Q1 2026 and has held it in 3 quarters since.
  • Bleichroeder's Cullinan Oncology position peaked at $4.55M in Q2 2026.
  • 125 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.